The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The development of these Statements would not have been possible without the input and support of a number of European based Patient Groups and Healthcare Professional Groups, who worked alongside our national associations that represent Hospital Pharmacists.
The starting point was a simple question, ‘what should patients expect of a hospital pharmacy service?’, with the added dimension of ‘how should hospital pharmacists contribute within the multidisciplinary team’.
What we have now is a set of Statements on which there is a consensus as to their importance. The Statement are not intended to be standards, some are aspirational and may take years to deliver while others are routed in the legislative framework provided by European Union and therefore obligatory for member states.
For Pharmaceutical Industry the most important aspect is that the Statements represent what patients want to ensure they have access to medicines that are safe and effective and that there is a hospital pharmacy service capable of delivering. There is a role for all parts of the Pharmaceutical Industry, from developing new medicines to meet patient need through to the supply of generics to improve cost effectiveness and to the many other companies that provide distribution, compounding and other specialist support to hospital pharmacies.
While all 44 of the Statements are relevant to the Pharmaceutical Industry you will find more information on those that are perhaps more relevant by clicking on the link below, ‘Who are the Statements for?’
Glossary of Terms
In developing the Statements it became clear that phrases meant very different things, not just between healthcare professionals and patients but also between hospital pharmacists. There was the additional challenge that the development process was undertaken in English, not the first language for the majority of those involved. As a consequence a Glossary of Terms was produced that clarified the intended meaning, i.e. the definition, of words and phrases that caused difficulty within the Statements together with the provision of a ‘source’ for that definition. The Glossary can be found here.
Medical Devices
Throughout the Statements, where the term medicines is used, medical devices are also included for countries in which hospital pharmacists have responsibility for this area. All the statements were agreed with the intention of improving the safety of patients.
Updating the Statements
Legislation and practice changes over time, so there will be a need to make sure the Statements remain current. Should you feel that something important to patient care has been over-looked or that a particular Statement is either not relevant any more or needs a major update because of legislative changes then please contact us at Statements@eahp.eu